Table 1.
Prevalence of mood and neurodevelopmental disorders in the general population and in the six experimental groups.
| Prevalence | Depression | Bipolar disorder | Anxiety disorder (including OCD) | Autism spectrum condition | ADHD/ADD | Dyslexia |
|---|---|---|---|---|---|---|
| General population, % | ||||||
| Male | 19 54 | – | 14 55 | 1 56 | 5 57 | – |
| Female | 27 54 | – | 23 55 | 0.1 56 | 4 57 | – |
| Both sexes | – | 2 58 | – | – | 2–11 59 | |
| XLI, % | ||||||
| Male | 31 | 2 | 31 | 10 | 19 | 6 |
| Female carrier | 45 | 1 | 30 | 1 | 10 | 3 |
| IV, % | ||||||
| Male | 35 | 4 | 22 | 0 | 4 | 0 |
| Female | 37 | 7 | 19 | 0 | 7 | 3 |
| Psoriasis, % | ||||||
| Male | 40 | 0 | 10 | 0 | 0 | 0 |
| Female | 33 | 1 | 25 | 0 | 2 | 0 |
ADD, attention deficit disorder; ADHD, attention deficit hyperactivity disorder; IV, ichthyosis vulgaris; OCD, obsessive–compulsive disorder; XLI, X‐linked ichthyosis.